ChemBriefGranules India profit surges as higher sales outweigh cost pressures
Indian drugmaker Granules India reported a nearly 40% surge in second-quarter profit driven by strong overseas sales despite rising material costs. The company supplies about one-third of global parac
reuters · 2026-11-02 03:46 UTC